Medtronic Less: comprehensive income attributable to noncontrolling interest increased by 133.3% to $7.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $7.00M to $7.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates that the company's subsidiaries are performing well, which increases the value attributable to noncontrolling interest holders.
The portion of total comprehensive income that is allocated to minority shareholders in subsidiaries that are consolidat...
Standard for any parent company with significant non-wholly owned subsidiaries.
other_comprehensive_income_net_of_tax_attributable_to_no_29ed8b| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $5.00M | $4.00M | $0.00 | $6.00M | $11.00M | $6.00M | $0.00 | $17.00M | $6.00M | $9.00M | $7.00M | $8.00M | $3.00M | $7.00M |
| QoQ Change | — | +25.0% | -20.0% | -100.0% | — | +83.3% | -45.5% | -100.0% | — | -64.7% | +50.0% | -22.2% | +14.3% | -62.5% | +133.3% |
| YoY Change | — | — | — | -100.0% | +20.0% | +175.0% | — | -100.0% | +54.5% | +0.0% | — | -58.8% | +33.3% | -66.7% | +0.0% |